Guangzhou Trinomab Biotech Co., Ltd. Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT02709616
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Trinomab Biotech Co., Ltd.